Cargando…

MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors

BACKGROUND: MicroRNA (miRNA) expression profiles have been described in pancreatic ductal adenocarcinoma (PDAC), but these have not been compared with pre-malignant pancreatic tumors. We wished to compare the miRNA expression signatures in pancreatic benign cystic tumors (BCT) of low and high malign...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiao, Long R., Frampton, Adam E., Jacob, Jimmy, Pellegrino, Loredana, Krell, Jonathan, Giamas, Georgios, Tsim, Nicole, Vlavianos, Panagiotis, Cohen, Patrizia, Ahmad, Raida, Keller, Andreas, Habib, Nagy A., Stebbing, Justin, Castellano, Leandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284550/ https://www.ncbi.nlm.nih.gov/pubmed/22384141 http://dx.doi.org/10.1371/journal.pone.0032068

Ejemplares similares

Sustained expression of miR-26a promotes chromosomal instability and tumorigenesis through regulation of CHFR
por: Castellano, Leandro, et al.
Publicado: (2017)

Prospective validation of microRNA signatures for detecting pancreatic malignant transformation in endoscopic-ultrasound guided fine-needle aspiration biopsies
por: Frampton, Adam E., et al.
Publicado: (2016)

Growth Arrest-Specific Transcript 5 Associated snoRNA Levels Are Related to p53 Expression and DNA Damage in Colorectal Cancer
por: Krell, Jonathan, et al.
Publicado: (2014)

CK1δ modulates the transcriptional activity of ERα via AIB1 in an estrogen-dependent manner and regulates ERα–AIB1 interactions
por: Giamas, Georgios, et al.
Publicado: (2009)

miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts
por: Pellegrino, Loredana, et al.
Publicado: (2013)

Can we predict long-term survival in resectable pancreatic ductal adenocarcinoma?
por: Gall, Tamara M.H., et al.
Publicado: (2019)

Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden
por: Frampton, Adam E., et al.
Publicado: (2018)

Lemur tyrosine kinase-3 (LMTK3) in cancer and evolution
por: Stebbing, Justin, et al.
Publicado: (2011)

The many-faced KSR1: a tumor suppressor in breast cancer
por: Zhang, Hua, et al.
Publicado: (2015)

The clinical significance of tumor infiltrating lymphoctyes in breast cancer: does subtype matter?
por: Krell, Jonathan, et al.
Publicado: (2012)

miR‐515‐5p controls cancer cell migration through MARK4 regulation
por: Pardo, Olivier E, et al.
Publicado: (2016)

Endocrine Resistance in Hormone Receptor Positive Breast Cancer–From Mechanism to Therapy
por: Rani, Aradhana, et al.
Publicado: (2019)

A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease
por: Mato Prado, Mireia, et al.
Publicado: (2023)

TP53 regulates miRNA association with AGO2 to remodel the miRNA–mRNA interaction network
por: Krell, Jonathan, et al.
Publicado: (2016)

Proteome-wide dataset supporting functional study of tyrosine kinases in breast cancer
por: Angelopoulos, Nicos, et al.
Publicado: (2016)

Deep sequencing of small RNAs identifies canonical and non-canonical miRNA and endogenous siRNAs in mammalian somatic tissues
por: Castellano, Leandro, et al.
Publicado: (2013)

Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis
por: Roca-Alonso, L, et al.
Publicado: (2015)

The Inhibitory Properties of a Novel, Selective LMTK3 Kinase Inhibitor
por: Agnarelli, Alessandro, et al.
Publicado: (2023)

Proteomic profile of KSR1-regulated signalling in response to genotoxic agents in breast cancer
por: Zhang, Hua, et al.
Publicado: (2015)

Characterization of the Tyrosine Kinase-Regulated Proteome in Breast Cancer by Combined use of RNA interference (RNAi) and Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) Quantitative Proteomics
por: Stebbing, Justin, et al.
Publicado: (2015)

A Prediction Model Using Alternative Splicing Events and the Immune Microenvironment Signature in Lung Adenocarcinoma
por: Zhu, Liping, et al.
Publicado: (2021)

ATG9A loss confers resistance to trastuzumab via c-Cbl mediated Her2 degradation
por: Nunes, Joao, et al.
Publicado: (2016)

Correction to: LMTK3 inhibition affects microtubule Stability
por: Cilibrasi, Chiara, et al.
Publicado: (2021)

LMTK3 inhibition affects microtubule stability
por: Cilibrasi, Chiara, et al.
Publicado: (2021)

A Pan-Cancer Analysis of SMARCA4 Alterations in Human Cancers
por: Peng, Ling, et al.
Publicado: (2021)

Reconstituting Immune Surveillance in Breast Cancer: Molecular Pathophysiology and Current Immunotherapy Strategies
por: Cilibrasi, Chiara, et al.
Publicado: (2021)

Extracellular Vesicles as Mediators of Therapy Resistance in the Breast Cancer Microenvironment
por: Samuels, Mark, et al.
Publicado: (2022)

TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression
por: Ottaviani, Silvia, et al.
Publicado: (2018)

Author Correction: TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression
por: Ottaviani, Silvia, et al.
Publicado: (2019)

Pancreatic Cysts: Diagnostic Role of EUS-Guided Microforceps Biopsy and Confocal Laser Endomicroscopy
por: Kohoutova, Darina, et al.
Publicado: (2019)

The germline of the malaria mosquito produces abundant miRNAs, endo-siRNAs, piRNAs and 29-nt small RNAs
por: Castellano, Leandro, et al.
Publicado: (2015)

The structure-function relationship of oncogenic LMTK3
por: Ditsiou, Angeliki, et al.
Publicado: (2020)

Shedding of bevacizumab in tumour cells-derived extracellular vesicles as a new therapeutic escape mechanism in glioblastoma
por: Simon, Thomas, et al.
Publicado: (2018)

Incorporating Immunotherapy in the Management of Gastric Cancer: Molecular and Clinical Implications
por: Agnarelli, Alessandro, et al.
Publicado: (2022)

Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway
por: Alshaker, Heba, et al.
Publicado: (2014)

Positive Outcomes in a Virtual Partial Hospitalization Program
por: Vlavianos, Theodore, et al.
Publicado: (2022)

Breast Cancer in the Setting of HIV
por: Palan, Mitul, et al.
Publicado: (2011)

Cancer gene therapy 2020: highlights from a challenging year
por: Giamas, Georgios, et al.
Publicado: (2021)

The Efficacy of Lapatinib in Metastatic Breast Cancer with HER2 Non-Amplified Primary Tumors and EGFR Positive Circulating Tumor Cells: A Proof-Of-Concept Study
por: Stebbing, Justin, et al.
Publicado: (2013)

A prognostic model of drug tolerant persister-related genes in lung adenocarcinoma based on single cell and bulk RNA sequencing data
por: Du, Zhonghai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9u3o7kg27e8m6ss991d74hu8bn